Comparison Tool

Select a country from the regions above then, add your country to our comparison tool to compare country specific information simultaneously across 3 countries


Fast Facts

  • Capital: Bangkok
  • Economy: 30th largest country, newly industrialised country, nominal GDP US$404 billion, 2014
  • Health Expenditure: 4.6% of GDP, 2013
  • Population: 67.2 million, 2014
  • Average Life Span: 71/79 (m/f), 2013
  • Languages: Thai
  • Adult Literacy Rate: 96.7% 2014

Health Trends

  • Thailand is well positioned to be a medical hub of Asia. The country offers state-of-the-art facilities and technologies, certified medical services, excellent medical expertise, highly qualified medical professionals and a wide range of high standard hospitals.
  • Health and medical care is overseen by the Ministry of Public Health, along with several other non-ministerial government agencies
  • 1,002 public hospitals and 316 registered private hospitals as of 2010.
  • Shift of main causes of death from communicable to lifestyle-related diseases. 
  • Major infectious diseases include HIV/AIDS, tuberculosis, bacterial diarrhoea, hepatitis, dengue fever, malaria, Japanese encephalitis, rabies, and leptospirosis
  • 61,082 victims of cancer in Thailand in 2011, 35,437 were male and 25,645 female and there is an increasing trend of patients with colon and rectal cancer.
  • Leading causes of death: stroke, HIV/AIDS, ischemic heart diseases, chronic obstructive lung diseases, diabetes and renal diseases.

Clinical Trial Landscape

  • Good Clinical Practice implemented in 2000.
  • Established institutions and expertise for the conduct of multinational clinical trials. 
  • Qualified and well trained medical professional from US or Europe with GCP certified and working in modern medical facilities.
  • There are several Clinical Research Centers (CRCs) at medical school hospitals. These CRCs also support and facilitate research activities in the hospital and provide training.
  • Sequential process for IEC and Thai FDA approval (import license). 
  • Therapeutic indications of strength locally include: Diabetes, Infectious diseases (Pneumonia, HIV, Malaria, Hepatitis B, Vaccines), Cardiovascular, Oncology, Gastroenterology and Neuropsychiatric diseases. 
  • Established centres for vaccine, malaria and HIV research.
  • To date 502 clinical trials (phase I, II, III, IV) have been registered in 
  • Top leading country for conduct clinical trials in South East Asia.

ICON in Thailand

Add to Comparison Tool
  • Presence in Thailand since 2001
  • Thai office opened in 2005 with CTM Management, CRA Management and Study start-up. 
  • Biostatistics
  • Leading for many therapeutic areas:
    • Oncology: NSCLC, Breast, Hepatocellular, Colorectal, Gastric, Prostate, Follicular Lymphoma, NHL 
    • Endocrinology: DM, Hyperlipidemia
    • Deficiency, Infection: HIV, Hep B, Hep C, Pneumonia, Skin Infection
    • Immune: RA, SLE
    • Blood system disorder: Anemia
    • Musculoskeletal disease: Osteoarthritis
    • Pulmonary: COPD, Asthma, TB
    • Cardiology: Hypertension, ACS, Atrial Fibrillation
    • Neuroscience: Alzheimer Disease, Pain, Stroke
    • Psychiatry: MDD, Schizophrenia, Bipolar
    • Gastroenterology: GERD, Gastric Ulcer
    • Vaccine: Influenza (Adult, Paediatric)
  • 1 USFDA and 2 Thai FDA inspections at sites: no issue from three inspections. 

Services Offered

  • Clinical trial application to ethics committees
  • Clinical trial application to ethics committees. 
  • Clinical trial dossier application to Thai FDA. 
  • Clinical Monitoring.
  • Study start-up activities
  • Clinical Trial Management

Contact Us for further information